Abstract This retrospective study details our experience regarding 72 patients with sacrococcygeal teratoma treated over a period of 17 years. The sex incidence was nearly equal, but there was a high proportion of Altmann type IV tumors. A preliminary colostomy before combined abdominosacral excision of large type III and IV lesions reduced morbidity. Sixty-six percent of the patients presented beyond the neonatal period; 14 had been treated elsewhere for bowel/urinary obstruction. Imaging studies included radiography, abdominal ultrasound, computed tomography, and magnetic resonance imaging (after 1995). In 60 patients the tumor was excised via the sacral route, 11 had a preliminary colostomy, and 1 had a vesicostomy. Eight children (5 with malignant lesions) required abdominosacral excision. After 1990, serial estimation of serum alpha-fetoprotein (AFP) was used to monitor tumor recurrence. There were 34 male and 38 female patients (age range 3 days-12 years); 47 had benign tumors, of which 42 were excised through the sacral route. Three patients underwent a preliminary colostomy and abdominosacral excision of the tumor with subsequent colostomy closure. There were 4 deaths in this group; no recurrence was seen in the surviving children with benign tumors. Twenty-five patients had malignant teratomas. In 18 of these the tumor was excised via the sacral route and 5 underwent abdominal-sacral excision. Eight had a preliminary colostomy and chemotherapy followed by excision of the residual tumor and colostomy closure. None of the initial 14 patients with malignant lesions survived beyond 2 years. Of the latter 11 (who received cisplatinumbased chemotherapy), 10 were alive 1 year after surgery. One patient is currently on preoperative chemotherapy and another developed recurrence of the tumor. The overall follow-up ranged from 3 months to 8 years; there has been no complaint of functional neurological deficit in any of the patients. As intrapelvic tumors tend to have a delayed diagnosis, this can be avoided by performing a rectal examination. There should be no recurrence after excision of a benign teratoma. Cisplatinum-based chemotherapy has improved the survival of patients with malignant tumors.
Introduction
Sacrococcygeal teratoma (SCT) is the commonest germcell tumor in children. The majority present in neonates as a sacral mass, however, some (totally intrapelvic) may be discovered late. This paper reports our experience with SCT over the past 17 years. A large proportion of these children had a delayed and misleading presentation with urinary or intestinal obstruction. The initial poor prognosis of malignant teratoma also showed improvement with cisplatinum-based chemotherapy.
Materials and methods
Seventy-two patients with SCT were seen in our department between January 1983 and January 2000. This was the largest group among 150 patients with retroperitoneal, ovarian, mediastinal, and head and neck teratomas [1] . The clinical records of all patients were reviewed; none of the tumors were diagnosed antenatally. There were 34 males and 38 females aged 3 days to 14 years (Table 1) . A digital rectal examination was the mainstay of clinical diagnosis.
Imaging studies included lateral sacral (initial 28 patients) and chest radiographs (30 patients with suspected malignant tumors). Abdominal ultrasound (US), barium enema, and micturating cystourethrography were done in 8 patients with intra-abdominal extension of the tumor. Computed tomograph. (CT) was done in 12 patients after its availability in 1990 and magnetic resonance imaging (MRI) in 2 patients after 1995. The tumors were grouped according to the scheme proposed by Altmann et al. [2] . Fourteen of the 19 patients with type IV tumors had been treated elsewhere for colonic obstruction and/or retention of urine.
Preoperatively, all patients had estimation of the hematocrit, serum creatinine, and electrolytes. Alpha-fetoprotein (AFP) assay became available in 1988, but was not used routinely as a preoperative investigation until after 1990. Surgery was usually performed through the sacral route, with excision of the coccyx in all cases. Type III/IV tumors with a large intra-abdominal component were removed by abdominosacral excision (8 patients). A preoperative colostomy was necessary in 11 patients (8 with malignant tumors and 3 with benign lesions with colonic obstruction). All specimens were subjected to histopathologic examination.
Results
Only 14% of the patients presented with a sacral mass in the neonatal period (Table 1 ). There were 47 benign tumors type I: 11, type II: 15, type III: 14, type IV-7, males 19, females 28) and 25 malignant teratomas.
All but 2 patients with benign lesions were operated upon. In 42, complete excision of the tumor including the coccyx was possible through the sacral route. The largest tumor was seen in a 2.5-year-old boy ( Fig. 1) : a benign type I lesion, uneventfully excised through the sacral route. Three patients with large intra-abdominal extension of the SCT and colonic obstruction had a preliminary transverse colostomy, abdomino sacral excision of the tumor, and subsequent colostomy closure. Three others children had atypical features: 1 presented with a small-bowel obstruction and rectal bleeding misdiagnosed as an intussussception), another had a cystic teratoma indistinguishable from a meningocele and the 3rd child underwent a vesicostomy elsewhere after being misdiagnosed as having posterior urethral valves. In all 3 cases the correct diagnosis was made by rectal examination.
Postoperative complications occurred in 2 patients: 1 necrosis of the flap margins due to thin skin and 1 wound infection due to fecal soiling. Four children died in this group (Table 2) , while 28 returned for follow-up, the longest period being 8 years. There was no tumor recurrence or functional problem in any of these patients.
Malignant teratomas included 3 type I, 13 type III, and 9 type IV, tumors (males: 15, females: 10). All these patients were older than 1 year. Eighteen had excision of the tumor through the sacral route and 5 required an abdomino-sacral operation. The patients with malignant tumors were sub-categorized into two groups: group 1, treated before 1990, and group 2, treated during the last 10 years of the study.
In group 1 (N = 14), children had sacral excision of the teratoma with postoperative chemo-and radiotherapy. Five (1 of whom had multiple discharging sinuses on the teratoma) had preoperative chemotherapy after biopsy of the tumor. Three of the latter required a preliminary colostomy, abdominosacral excision with removal of the densely adherent rectum en bloc with the tumor, and subsequent colostomy closure. The other 2 tumors were excised through the sacral route. With 1 exception, none of these children lived beyond 1 year (Table 2) . A female who had received preoperative chemotherapy developed a recurrent tumor nodule at the vulva, which was excised uneventfully. She was lost to follow-up after 4 years.
In group 2 (N = 11), 5 patients had excision of the teratoma with post-operative chemo-and radiotherapy. Five others with large type III tumors and colonic obstruction had a transverse colostomy after tumor biopsy followed by cisplatinum-based chemotherapy, after Male  4  3  1  Female  8  5  1  II  Male  4  2  1  Female  1  2  4  III  Male  2  6  2  Female  1  3  3  IV  Male  1  2  6  Female  3  2  5  Total  24  25 23 Fig. 1 . Large sacrococcygeal tumor (type I, uneventfully excised through sacral route) which 3 tumors reduced considerably in size. Excision of the residual mass through the sacral route with simultaneous colostomy closure was then performed uneventfully in these 3 cases. The 2 remaining children had abdominosacral excision with subsequent colostomy closure. All patients in group II are alive, with the longest follow-up being 1 year. There has been 1 recurrence, and this child is currently on chemotherapy. The last patient was a 14-year-old girl with a type IV malignant SCT invading the sacrum (Fig. 2) who presented with lower-limb neuralgia and incontinence. She is currently on chemotherapy following biopsy. Postoperative complications were seen in 2 patients with malignant tumors: 1 had a rectal injury during the operation. A colostomy was performed, but a wound infection ensued that was managed conservatively. Another patient had abdominal wound dehiscence following abdominosacral excision. Recovery was uneventful after re-suture. Discussion SCT, the most common extragonadal germ-cell tumor of childhood, is frequently diagnosed antenatally and treated in the neonatal period [3, 4] . Patients with intrapelvic tumors or those who have an atypical presentation (bowel/urinary obstruction) are, however, diagnosed late. In the present study the male-to-female ratio was nearly equal, in contrast to the universal female preponderance reported [2] [3] [4] [5] , and the incidence of type IV tumors was equal to that of type I, which is probably a regional variation.
Sixty-six percent of our patients were first seen beyond the neonatal period (50% females) and 33% at ages older than 1 year; this is significant in relation to the known propensity of these tumors for malignant transformation. Of the patients with type IV lesions, 70% were referred late after being unsuccessfully treated for bowel or urinary obstruction. We emphasize that a rectal examination is the most useful maneuver to establish the correct diagnosis, especially when there is an unusual presentation of this tumor [6] . X-ray films of the sacrum may show calcification, and a contrast enema reveals posterior indentation of the rectum. CT and MRI are useful to differentiate a SCT from other presacral masses and define the extent of the tumor. US is used to assess the renal tracts and radiography of the chest to detect metastases.
There were no recurrences in patients with benign tumors; the coccyx was completely excised in all cases. The postoperative complications could be managed conservatively. Malignant recurrence after excision of benign tumors has been reported in the literature [5, 7] , sometimes despite excision of the coccyx. A wound infection occurred after a rectal injury in 1 of our early abdominosacral operations. We have since performed a preliminary colostomy when planning an abdominosacral excision, especially if there is a history of colonic obstruction. This reduces morbidity considerably, especially if adherent bowel has to be excised en bloc with the teratoma. At operation, the abdominal component of the tumor is dissected free before placing the child in the prone position. We have not required aortic control in any patient, even with large tumors. The pedicle of the tumor is usually small (Fig. 1) , and control of the presacral vessels after division of the sacrococcygeal junction permits excision without problems.
The prognosis of malignant SCT showed improvement in the latter period of the study: only 1 of our initial 14 patients survived beyond 2 years, but all of the latter 11 are alive at 1 year with recurrence in only 1 case. Unfortunately, the parents of this child had not complied with regular estimation of serum AFP levels. The recurrence was detected when the mother noticed the sacral mass. More children with malignant teratomas are now being monitored by serial AFP estimation. The most important reasons for the improved prognosis are cisplatinum-based chemotherapy and the recent availability of a pediatric oncology service in our hospital. Preoperative chemotherapy after biopsy of the tumor in patients over the age of 1 year with large tumors and intrapelvic extension has also improved the outcome. A preliminary colostomy is performed if there is colonic obstruction. Few complications were seen, and they could be managed conservatively. There have been recent reports of functional sequelae after excision of SCTs [8] [9] [10] . None of our patients have reported any problems of this nature during follow-up.
In conclusion, SCT is amenable to cure provided it is detected early and managed appropriately. In our country delayed presentation/referral is a problem, but increasing awareness of this condition should lead to earlier referral for treatment and improve the prognosis.
